Avax Technologies

Avax Technologies, Inc ({OTCPink|AVXT}) is a Philadelphia based biotechnology company whose most advanced product candidate is MVax for melanoma. MVax is a cancer vaccine that received a Special Protocol Assessment agreement with the FDA in October 2006, and subsequently began a Phase III registration clinical trial in November 2007 . In previous ...
Found on http://en.wikipedia.org/wiki/Avax_Technologies
No exact match found